Key Takeaways
- • Venture capital invested $11.4 billion across 646 radiology companies between 2000 and 2023, with 2,851 VC firms making 2,584 total investments, according to research published December 15 in the Journal of the American College of Radiology.
- • Investment activity peaked in 2021 at $2.2 billion before declining in subsequent years, with the average per-investment valuation reaching $51 million post-funding.
- • Medical devices and AI healthcare software dominated capital allocation, each attracting 28% of total venture investment, signaling investor focus on automation and diagnostic innovation.
- • Average initial investment size was $6.3 million per deal, indicating a mix of seed through late-stage funding across the radiology innovation ecosystem.
- • The research, led by Anirudh Bikmal of Emory University, fills a significant data gap in understanding private capital's role in reshaping radiology innovation and commercialization.
Summary
Venture capital activity in radiology has grown substantially over the past two decades, with new research documenting the scale and trajectory of private capital deployment in the sector. Between 2000 and 2023, 2,851 venture capital firms deployed $11.4 billion across 2,584 investments in 646 radiology-focused companies, according to a study published December 15 in the Journal of the American College of Radiology. The research, conducted by a team led by Anirudh Bikmal from Emory University in Atlanta, represents one of the first comprehensive analyses of venture capital trends specific to radiology, addressing what researchers described as limited available data on investment patterns in the specialty.
The capital deployment accelerated significantly over the study period, peaking in 2021 at $2.2 billion before moderating in subsequent years. The average investment per deal stood at $6.3 million, with median post-investment company valuations reaching $51 million, reflecting a mix of seed-stage through late-stage financing across the radiology innovation landscape. The researchers categorized investments across six primary sectors: medical devices, healthcare services, AI healthcare software, non-AI healthcare software, consumer goods, and biotechnology and drug discovery.
Medical devices and AI healthcare software emerged as the primary investment targets, each capturing 28% of total capital deployed. This distribution underscores investor appetite for technology-enabled diagnostic solutions and hardware innovation. The research team leveraged the Pitchbook database to track funding rounds and assessed downstream innovation metrics including clinical trials, international patent filings, and company exits. Bikmal and colleagues noted in their findings that "this trend underscores the increasing role of private capital in shaping innovation within radiology," highlighting the sector's importance as a testing ground for venture-backed healthcare innovation and commercialization strategies.
The capital deployment accelerated significantly over the study period, peaking in 2021 at $2.2 billion before moderating in subsequent years. The average investment per deal stood at $6.3 million, with median post-investment company valuations reaching $51 million, reflecting a mix of seed-stage through late-stage financing across the radiology innovation landscape. The researchers categorized investments across six primary sectors: medical devices, healthcare services, AI healthcare software, non-AI healthcare software, consumer goods, and biotechnology and drug discovery.
Medical devices and AI healthcare software emerged as the primary investment targets, each capturing 28% of total capital deployed. This distribution underscores investor appetite for technology-enabled diagnostic solutions and hardware innovation. The research team leveraged the Pitchbook database to track funding rounds and assessed downstream innovation metrics including clinical trials, international patent filings, and company exits. Bikmal and colleagues noted in their findings that "this trend underscores the increasing role of private capital in shaping innovation within radiology," highlighting the sector's importance as a testing ground for venture-backed healthcare innovation and commercialization strategies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.